ARTICLE | Company News
Celgene, Nogra Pharma deal
April 28, 2014 7:00 AM UTC
Nogra granted Celgene exclusive, worldwide rights to develop and commercialize GED-0301 to treat moderate to severe Crohn's disease (CD) and other gastrointestinal indications. Nogra (formerly Giuli...